David Shoultz
Fondatore presso Monod Bio, Inc.
Profilo
David Shoultz is the founder of Monod Bio, Inc. which is founded in 2021, where he holds the title of Chief Operating Officer & Director.
He is currently working as a Director at The Geneva Foundation.
Posizioni attive di David Shoultz
Società | Posizione | Inizio |
---|---|---|
The Geneva Foundation
The Geneva Foundation Miscellaneous Commercial ServicesCommercial Services The Geneva Foundation provides medical research and excellence in education within the U.S. military. Its services include proposal development, program management, federal contracts, clinical trials, conferences and events and educational support. The company was founded in by Jane S. Taylor in 1993 and is headquartered in Tacoma, WA. | Direttore/Membro del Consiglio | - |
Monod Bio, Inc.
Monod Bio, Inc. Electronic Equipment/InstrumentsElectronic Technology Monod Bio, Inc. specializes in de novo enzyme design. The company is based in Seattle, WA. The company uses a deep-learning-based approach to generate idealized protein structures with diverse pocket shapes. The company was founded by Alfredo Quijano Rubio, David Shoultz. Daniel Silva Manzano has been the CEO of the company since 2021. | Fondatore | 01/10/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
The Geneva Foundation
The Geneva Foundation Miscellaneous Commercial ServicesCommercial Services The Geneva Foundation provides medical research and excellence in education within the U.S. military. Its services include proposal development, program management, federal contracts, clinical trials, conferences and events and educational support. The company was founded in by Jane S. Taylor in 1993 and is headquartered in Tacoma, WA. | Commercial Services |
Monod Bio, Inc.
Monod Bio, Inc. Electronic Equipment/InstrumentsElectronic Technology Monod Bio, Inc. specializes in de novo enzyme design. The company is based in Seattle, WA. The company uses a deep-learning-based approach to generate idealized protein structures with diverse pocket shapes. The company was founded by Alfredo Quijano Rubio, David Shoultz. Daniel Silva Manzano has been the CEO of the company since 2021. | Electronic Technology |
- Borsa valori
- Insiders
- David Shoultz